FDA approves Lymphoseek for head and neck cancer determination
The most common side effects identified in clinical trial was pain or irritation at the injection site
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Archive » Research Archive » Page 3
Browsing Category
Research Archive
FDA approves Afrezza to treat diabetes
The US Food and Drug Administration approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve…
FDA approves Beleodaq
The US Food and Drug Administration approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma…
Piramal’s NCE research shares preclinical efficacy data for two promising molecules
Piramal Life Sciences - NCE Research, a division of Piramal Enterprises Ltd (PEL), made poster presentations for drugs in early…
Tau Imaging Agents to Advance Treatment of Alzheimer
Tau imaging agents could offer the next frontier in neuroimaging for diseases such as Alzheimer’s disease (AD) and other forms of…
Failing animal research is delaying cures for Alzheimer’s disease: Study
Research recommends utilising advanced technology based on human rather than non-human biology
US FDA seeks further evidence on efficacy of Novartis’ RLX030
Novartis announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the…
Drug therapy for allergy moves forward
Traditionally, drug therapy for allergy is based on the use of non-sedative antihistamines
Novartis gains US FDA approval for Zykadia
Zykadia (ceritinib) demonstrates an overall response rate of 54.6 per cent in patients with ALK+ metastatic NSCLC